Conference Coverage
Conference Coverage
BRAF-Plus-MEK Inhibition Slows Melanoma
Conference Coverage
Docs Need Primer on Long-Term Effects of Chemotherapy
Major Finding: Only 6% of primary care physicians were able to identify the main long-term effects of doxorubicin, paclitaxel, oxaliplatin and...
Conference Coverage
Early Detection of Melanoma: Harnessing Untapped Resources
Conference Coverage
Propranolol Considered Standard of Care for Infantile Hemangiomas
Conference Coverage
Gains in Melanoma Survival Attributed to Patient Awareness
Conference Coverage
Total Body Exam Reduces Melanoma Mortality
Conference Coverage
Slowed Infusions Cut Hypersensitivity Reactions in Rituximab Desensitization
Major Finding: Rituximab desensitization by standard infusion resulted in a 29% hypersensitivity-reaction rate, but rate-controlled infusion...
Conference Coverage
Off-Label Use of Aprepitant Quells Refractory Pruritus
Conference Coverage
58-Plus Chromosomes Bode Well in Childhood B-ALL
Major Finding: Children with B-lineage acute lymphoblastic leukemia who had a modal number of chromosomes (MNC) ranging from 58-66 had a 6-year...
Conference Coverage
Pregnant Women With Lymphoma Can Have Good Outcomes
Major Finding: Among women with lymphomas diagnosed during pregnancy, the 3-year progression-free survival rates were 76% in women who underwent...
Conference Coverage
IGF-I Doesn't Predict Late Complications in Childhood Cancer Survivors
Major Finding: Among childhood cancer survivors who had low IGF-I levels and received growth hormone stimulation, IGF-I z scores did not did not...